论文部分内容阅读
目的对采用静脉溶栓疗法对患有急性心肌梗死的患者进行治疗的临床效果进行研究分析。方法抽取80例患有急性心肌梗死的临床确诊患者的临床资料,将其分为A、B两组,每组40例。分别采用尿激酶和阿替普酶进行静脉溶栓治疗。结果 B组临床治疗效果明显优于A组,治疗过程中出现并发症的例数明显少于A组,治疗后左室射血分数和左室舒张末径水平明显高于A组。结论采用阿替普酶对患有急性心肌梗死的患者进行静脉溶栓治疗的临床效果非常理想。
Objective To study the clinical effect of intravenous thrombolytic therapy on patients with acute myocardial infarction. Methods Clinical data of 80 clinically diagnosed patients with acute myocardial infarction were collected and divided into groups A and B, 40 cases in each group. Urokinase and alteplase were used for intravenous thrombolysis. Results The clinical effect of group B was better than that of group A. The number of complications during treatment was significantly less than that of group A. The left ventricular ejection fraction and left ventricular end-diastolic diameter were significantly higher than those of group A after treatment. Conclusion The effect of intravenous thrombolytic therapy with alteplase in patients with acute myocardial infarction is very satisfactory.